Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.12 USD
Change Today +0.0025 / 2.19%
Volume 143.8K
As of 8:10 PM 06/29/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mark L. Faupel Ph.D.

Chief Scientific Officer, Guided Therapeutics, Inc
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

59$294,697
As of Fiscal Year 2014

Background*

Dr. Mark L. Faupel, Ph.D. has been the Chief Scientific Officer of Guided Therapeutics, Inc. since January 7, 2014. and served as its Principal Accounting Officer. Dr. Faupel served as an Acting Chief Financial Officer of Guided Therapeutics, Inc. since June 12, 2007 until January 2014. Dr. Faupel served as the President of Guided Therapeutics, Inc. since January 17, 2007 until January 2014. Dr. Faupel has been and served as its Chief Executive Officer from May 14, 2007 ...

Read Full Background

Corporate Headquarters*

5835 Peachtree Corners East
Norcross, Georgia 30092

United States

Phone: 770-242-8723
Fax: 770-242-8639

Board Members Memberships*

2007-N/A
Chief Scientific Officer

Education*

PhD
University of Georgia

Other Affiliations*

Annual Compensation*

Salary$264,097
Bonus$13,600
Total Annual Compensation$277,697

Stock Options*

Exercisable Options2,155,832
Total Number of Options2,184,999

Total Compensation*

Total Annual Cash Compensation$277,697
Total Short Term Compensation$277,697
Total Calculated Compensation$294,697
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GTHP:US $0.12 USD +0.0025

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Stephen P. Macmillan Chairman of the Board, Chief Executive Officer and President
Hologic Inc.
$792.3K
L. Michael Hone Chief Executive Officer and Director
Caliber Imaging & Diagnostics, Inc.
$350.0K
Sacha Loiseau Ph.D.Founder, Chief Executive Officer and Director
Mauna Kea Technologies SAS
€205.0K
Michael R. Stewart Chief Executive Officer, President and Director
MELA Sciences, Inc.
$14.1K
Thomas A. Braun BA, J.D., LLMChief Executive Officer, President, Director, Member of Compensation Committee and Member of Audit Committee
Verisante Technology, Inc.
C$312.5K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GUIDED THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.